Article Details
Retrieved on: 2023-01-10 19:09:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Other equities analysts have also issued reports about the company. The Goldman Sachs Group set a GBX 6,950 ($84.67) price target on AstraZeneca in a ...
Article found on: www.etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here